Intermittent Theta Burst Stimulation of the Prefrontal Cortex in Social Anxiety Disorder
Intermittent Theta-Burst Stimulation Targeting the Prefrontal Cortex for Social Anxiety Disorder: A Randomized, Parallel-Group Comparative Study
1 other identifier
interventional
100
1 country
1
Brief Summary
This study aims to investigate the therapeutic effects of intermittent theta burst stimulation on social anxiety disorder and to track physiological changes in the brain using electroencephalography (EEG). Eligible SAD participants, after voluntarily signing an informed consent form, will first complete basic information collection, baseline questionnaire completion, and a pre-treatment EEG data collection session lasting approximately 30 minutes (including resting-state and task-state recordings). Subsequently, participants will be randomly assigned to one of three groups (left iTBS group, right iTBS group, or sham stimulation group) to receive intensive treatment for one week (4 sessions daily for 5 consecutive days, totaling 20 sessions). Immediately following the intervention, the research team will conduct post-treatment EEG data collection and gather questionnaire assessments. Participants will also undergo follow-up visits at weeks 2, 4, 6, and 8 post-treatment to complete questionnaires and report any adverse events. All study procedures are strictly and safely conducted by trained professionals. Participation is entirely voluntary, and participants may withdraw unconditionally at any time during the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 9, 2025
CompletedFirst Submitted
Initial submission to the registry
March 4, 2026
CompletedFirst Posted
Study publicly available on registry
March 12, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
March 12, 2026
December 1, 2025
12 months
March 4, 2026
March 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline in Liebowitz Social Anxiety Scale (LSAS) Total Score
The LSAS is used to assess the severity of social anxiety symptoms by evaluating fear and avoidance across multiple social and performance situations. The total score ranges from 0 to 144. Higher scores indicate greater severity of social anxiety symptoms (worse outcome).
Baseline, immediately post-intervention (Week 1), and at Weeks 2, 4, 6, and 8 post-intervention.
Secondary Outcomes (4)
Change from Baseline in Hamilton Anxiety Rating Scale (HAMA) Total Score
Baseline, immediately post-intervention (Week 1), and at Weeks 2, 4, 6, and 8 post-intervention.
Change from Baseline in Hamilton Depression Rating Scale (HAMD) Total Score
Baseline, immediately post-intervention (Week 1), and at Weeks 2, 4, 6, and 8 post-intervention.
Change from Baseline in Pittsburgh Sleep Quality Index (PSQI) Score
Baseline, immediately post-intervention (Week 1), and at Weeks 2, 4, 6, and 8 post-intervention.
Change from Baseline in Resting-State and Task-State Electroencephalogram (EEG) Metrics
Baseline and immediately post-intervention (Week 1).
Study Arms (3)
Left PFC-iTBS
EXPERIMENTALParticipants will receive active intermittent theta-burst stimulation (iTBS) targeting the left prefrontal cortex.
Right PFC-iTBS
EXPERIMENTALParticipants will receive active intermittent theta-burst stimulation (iTBS) targeting the right prefrontal cortex.
Sham iTBS
SHAM COMPARATORParticipants will receive sham intermittent theta-burst stimulation (iTBS) targeting the prefrontal cortex.
Interventions
Active iTBS is delivered using a real "figure-8" coil targeting the prefrontal cortex. Stimulation is delivered at 120% of the resting motor threshold (RMT). The protocol consists of 3 sets of 50 Hz pulses repeated at 5 Hz (2s on, 8s off), totaling 1,800 pulses per session. The intensive treatment schedule includes 4 sessions per day for 5 consecutive days (1 week), totaling 20 sessions.
Sham iTBS is delivered using a visually identical sham "figure-8" coil. It produces similar acoustic clicks and scalp somatic sensations to mimic the active treatment, ensuring participant blinding. However, it uses same-direction currents causing opposing central currents, resulting in near-zero focal magnetic induction without therapeutic effect. The session schedule and apparent parameters strictly match the active group (4 sessions/day for 5 days).
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, 310013, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lei Lei Zheng, MD
Second Affiliated Hospital, School of Medicine, Zhejiang University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2026
First Posted
March 12, 2026
Study Start
December 9, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
March 12, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Data will become available beginning 9 months and ending 36 months following article publication.
- Access Criteria
- Data will be shared with researchers who provide a methodologically sound proposal to achieve aims in the approved proposal. Proposals should be directed to the corresponding author. To gain access, data requestors will need to sign a formal data access agreement, ensuring compliance with local data protection regulations regarding sensitive psychiatric data.
De-identified individual participant data (IPD) that underlie the results reported in this article will be shared. This includes clinical assessment scores and extracted neurophysiological (EEG) feature data.